Structural features of α-synuclein amyloid fibrils revealed by Raman spectroscopy
暂无分享,去创建一个
Jennifer C. Lee | R. Walker | Jennifer C Lee | Robert L Walker | Ryan P McGlinchey | Jessica D Flynn | Jessica D. Flynn | R. McGlinchey | R. Walker
[1] Jennifer C. Lee,et al. Biophysics of α-synuclein membrane interactions. , 2012, Biochimica et biophysica acta.
[2] D. Selkoe,et al. In Vivo Cross-linking Reveals Principally Oligomeric Forms of α-Synuclein and β-Synuclein in Neurons and Non-neural Cells* , 2013, The Journal of Biological Chemistry.
[3] T. Roemer,et al. Antifungal drug development: challenges, unmet clinical needs, and new approaches. , 2014, Cold Spring Harbor perspectives in medicine.
[4] C. Dobson,et al. Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.
[5] Ronald Melki,et al. G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndrome , 2013, Annals of neurology.
[6] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[7] E. Masliah,et al. The many faces of α-synuclein: from structure and toxicity to therapeutic target , 2012, Nature Reviews Neuroscience.
[8] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[9] Saikat Ghosh,et al. The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro. , 2013, Biochemistry.
[10] Peter T. Lansbury,et al. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.
[11] Paul R. Carey,et al. Secondary Structure of α-Synuclein Oligomers: Characterization by Raman and Atomic Force Microscopy , 2006 .
[12] Susan E Daniel,et al. Characterisation of isolated α-synuclein filaments from substantia nigra of Parkinson's disease brain , 2000, Neuroscience Letters.
[13] H. Levine. Quantification of beta-sheet amyloid fibril structures with thioflavin T. , 1999, Methods in enzymology.
[14] L. Serpell,et al. Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[15] R. Riek,et al. Structure based aggregation studies reveal the presence of helix-rich intermediate during α-Synuclein aggregation , 2015, Scientific Reports.
[16] Jennifer C. Lee,et al. Taking a Bite Out of Amyloid: Mechanistic Insights into α-Synuclein Degradation by Cathepsin L. , 2017, Biochemistry.
[17] Ewan W Blanch,et al. A new perspective on beta-sheet structures using vibrational Raman optical activity: from poly(L-lysine) to the prion protein. , 2003, Journal of the American Chemical Society.
[18] E. Valente,et al. Phenotypic spectrum of alpha-synuclein mutations: New insights from patients and cellular models. , 2016, Parkinsonism & related disorders.
[19] Nicholas K. Sauter,et al. Structure of the toxic core of α-synuclein from invisible crystals , 2015, Nature.
[20] M. Giugliano,et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration , 2015, Nature.
[21] Nikolaos N. Louros,et al. Tracking the amyloidogenic core of IAPP amyloid fibrils: Insights from micro-Raman spectroscopy. , 2017, Journal of structural biology.
[22] Bernard Schneider,et al. α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer* , 2012, The Journal of Biological Chemistry.
[23] Jiajie Diao,et al. Properties of native brain α-synuclein , 2013, Nature.
[24] Andrew J. Nieuwkoop,et al. Structured regions of α-synuclein fibrils include the early-onset Parkinson's disease mutation sites. , 2011, Journal of molecular biology.
[25] V. Uversky,et al. Is Congo Red an Amyloid-specific Dye?* , 2001, The Journal of Biological Chemistry.
[26] Jennifer C. Lee,et al. Tryptophan probes at the alpha-synuclein and membrane interface. , 2010, The journal of physical chemistry. B.
[27] A. Steven,et al. α-Synuclein Amyloid Fibrils with Two Entwined, Asymmetrically Associated Protofibrils* , 2015, The Journal of Biological Chemistry.
[28] B. Meier,et al. Structural and functional characterization of two alpha-synuclein strains , 2013, Nature Communications.
[29] V. Uversky,et al. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. , 2001, Biochemistry.
[30] A. Talari,et al. Raman Spectroscopy of Biological Tissues , 2007 .
[31] Charles D. Schwieters,et al. Solid-State NMR Structure of a Pathogenic Fibril of Full-Length Human α-Synuclein , 2016, Nature Structural &Molecular Biology.
[32] Henning Stahlberg,et al. The fold of α-synuclein fibrils , 2008, Proceedings of the National Academy of Sciences.
[33] P. Lansbury,et al. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. , 2000, Biochemistry.
[34] T. Südhof,et al. α-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation , 2014, Proceedings of the National Academy of Sciences.
[35] Paul H. Axelsen,et al. The E46K Mutation in α-Synuclein Increases Amyloid Fibril Formation* , 2005, Journal of Biological Chemistry.
[36] M. Hosokawa,et al. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. , 1989, Analytical biochemistry.
[37] Ashutosh Kumar,et al. Perturbation in Long-Range Contacts Modulates the Kinetics of Amyloid Formation in α-Synuclein Familial Mutants. , 2017, ACS chemical neuroscience.
[38] C. Rienstra,et al. Preparation of alpha-synuclein fibrils for solid-state NMR: expression, purification, and incubation of wild-type and mutant forms. , 2006, Protein expression and purification.
[39] M. Citron,et al. Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation* , 1999, The Journal of Biological Chemistry.
[40] R. Melki,et al. Structural and functional properties of prefibrillar α-synuclein oligomers , 2016, Scientific Reports.
[41] Patrik Brundin,et al. Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein , 2002, Nature Reviews Neuroscience.
[42] N. Maiti,et al. Raman spectroscopic characterization of secondary structure in natively unfolded proteins: alpha-synuclein. , 2004, Journal of the American Chemical Society.
[43] R. V. Van Duyne,et al. Exploring the structure and formation mechanism of amyloid fibrils by Raman spectroscopy: a review. , 2015, The Analyst.
[44] L. Serpell,et al. Fiber diffraction of synthetic a-synuclein filaments shows amyloid-like cross-b conformation , 2000 .
[45] S. Lane,et al. Micro-Raman spectroscopy detects individual neoplastic and normal hematopoietic cells. , 2006, Biophysical journal.
[46] S. Becker,et al. Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[47] Jeannie Chen,et al. Investigation of α-Synuclein Fibril Structure by Site-directed Spin Labeling* , 2007, Journal of Biological Chemistry.
[48] L. Stefanis. α-Synuclein in Parkinson's disease. , 2012, Cold Spring Harbor perspectives in medicine.
[49] Jennifer C. Lee,et al. Cysteine cathepsins are essential in lysosomal degradation of α-synuclein , 2015, Proceedings of the National Academy of Sciences.
[50] H. Deng,et al. Genetic variants and animal models in SNCA and Parkinson disease , 2014, Ageing Research Reviews.
[51] H. Levine,et al. Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.
[52] P. Carey,et al. Raman crystallography and other biochemical applications of Raman microscopy. , 2006, Annual review of physical chemistry.
[53] V. Uversky,et al. Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation* , 2001, The Journal of Biological Chemistry.
[54] A. Kaczor,et al. Raman spectroscopy of proteins: a review , 2013 .